description	ground truth	output
The molecule is a apoptosis and a cholesterol translocation that impacts diabetic heart disease, barth syndrome, and aging. The molecule is a stabilizing cytochrome oxidase, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts tangier disease and non-alcoholic fatty liver disease.	CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a stabilizing mitochondrial structure and a apoptosis that impacts diabetic heart disease, tangier disease, and barth syndrome. The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts aging and non-alcoholic fatty liver disease.	CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCC(C)C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCCCC
The molecule is a energy storage, nutrient, membrane stabilizer that impacts cardiovascular disease, metabolic syndrome, and pancreatitis. The molecule is a member of the thyroxine treatment class and affects both atherosclerosis and cancer. The molecule is a fat storage, a energy source, and a inflammatory, and it impacts obesity.	CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCC(C)C	CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)C
The molecule is a stabilizing cytochrome oxidase and a stabilizing mitochondrial structure that impacts diabetic heart disease, aging, and barth syndrome. The molecule is a cholesterol translocation, apoptosis, proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease and tangier disease.	CCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCC(C)C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCCCC
The molecule is a protein kinase inhibitor and pdk1 inhibitor, and it impacts cancer treatment.	Cc1[nH]c(C=C2C(=O)Nc3cc(C=CCNc4ncccc4C(=O)NCc4ccc(F)c(F)c4)ccc32)c(C)c1C(=O)O	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
When heated to decomposition it emits acrid smoke and irritating fumes. The molecule has both a Bitter and unpleasant taste and a Pleasant odor.	COc1ccc(C(C)=O)cc1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, apoptosis that impacts aging and non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation and a stabilizing cytochrome oxidase that impacts diabetic heart disease, tangier disease, and barth syndrome.	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC
The molecule is a apoptosis and a stabilizing mitochondrial structure that impacts tangier disease, aging, and non-alcoholic fatty liver disease. The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts diabetic heart disease and barth syndrome.	CCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCC(C)C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a proton trap for oxidative phosphorylation, a membrane stabilizer, and a surfactant, and it impacts non-alcoholic fatty liver disease. The molecule is a cholesterol translocation and a apoptosis, which impacts both diabetic heart disease and barth syndrome, and is characterized as smooth. The molecule is a food additive, a energy storage, and a emulsifier, and it impacts tangier disease. The molecule is a energy source, nutritional supplement, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts aging.	CC(C)CCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCC(C)C)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC(C)C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a apoptosis and a cholesterol translocation that impacts barth syndrome, diabetic heart disease, and aging. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease and tangier disease.	CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC(C)C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a flavoring agent, savory, meaty, and sulfur.	COc1cc(C(=O)CO)cc(OC)c1O	CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](N)C(=O)O)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCCCC
The molecule is both a hcv inhibitor and a anti viral.	COc1ccc2c(c1)c(C#N)c(-c1ccc(NS(=O)(=O)C3CC3)cc1)n2C1CCC1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
It impacts thyroxine treatment, metabolic syndrome, and pancreatitis. The molecule is a fat storage and a nutrient, impacting both cardiovascular disease and atherosclerosis.	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCC/C=C\C/C=C\CCCCC)COC(=O)CCCCCCCCCCC/C=C\CCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COC(=O)CCCCCCCCC/C=CC/C=CC/C=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC
The molecule is anti bacterial.	CC(=O)Nc1ccc([N+](=O)[O-])c(-c2ccncc2)n1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts tangier disease and non-alcoholic fatty liver disease. The molecule is a cholesterol translocation and a apoptosis that impacts aging, barth syndrome, and diabetic heart disease.	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
It impacts diabetes mellitus type 1, cardiovascular disease, and diabetes mellitus type 2. The molecule is a nutrient that impacts insulin resistance, atherosclerosis, and pick's disease.	CC/C=C\C/C=C\CC(O)/C=C/C=C\C/C=C\CCCC(=O)N[C@@H](COP(=O)([O-])OCC[N+](C)(C)C)[C@H](O)CCCCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is anti oxidant.	C=C(C(=CC1C(O)=CC(O)=CC1C)CC1CC(O)C(O)C(O)C1O)c1ccc(O)c(O)c1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a member of the thyroxine treatment class and affects both metabolic syndrome and cardiovascular disease. The molecule is a fat storage and a nutrient, impacting both pancreatitis and atherosclerosis.	CCCC/C=C\CCCCCCCC(=O)OC[C@@H](COCCCCCCCCCCCCCCCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\CCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COC(=O)CCCCCCCCC/C=CCCCCCCCC)OC(=O)CCCCCCCCC/C=CCCCCCCCC
The molecule is a thrombin inhibitor and belongs to the thrombosis treatment class of molecules.	COC(=O)Cc1cn(-c2cc(C)ccn2)cn1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
The molecule is a apoptosis that impacts tangier disease, barth syndrome, non-alcoholic fatty liver disease, and aging. The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts diabetic heart disease.	CCCCC/C=C\C/C=C\CCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCC/C=C\CCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=CC/C=CC/C=CCCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC
The molecule is a anti viral.	CCC(C)(C)C1CC(F)(F)CC1C(N)=O	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
It impacts cardiovascular disease, stomach cancer, parkinson's disease, and colorectal cancer. It has an effect on breast cancer, and impacts alzheimer's disease, diabetes mellitus, and seizure.	CCCCCCCC/C=C\CCCCCCCC(=O)O[C@@H]1COC(=O)CCC/C=C\C[C@H]2C=CC(=O)[C@H](/C=C/[C@@H](O)CCCCC)[C@@H](O)[C@@H](O)[C@@H](OP(=O)(O)OC1)[C@H](O)[C@@H](O)[C@@H]2O	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)O[C@H]1C(O)C(O)C(O)[C@@H](OP(=O)(O)O)C1O)OC(=O)CCC/C=CC/C=CC/C=CCCCC
The molecule is thyroxine treatment and it impacts both metabolic syndrome and pancreatitis. The molecule is a fat storage and a nutrient, impacting both cardiovascular disease and atherosclerosis.	CCCCCCCC/C=C\CCCCCCCCCC(=O)OC[C@@H](COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COC(=O)CCCCCCCCC/C=CC/C=CC/C=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC
The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, cholesterol translocation that impacts barth syndrome and diabetic heart disease. The molecule is a apoptosis and a stabilizing mitochondrial structure that impacts tangier disease, non-alcoholic fatty liver disease, and aging.	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC
The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts aging, non-alcoholic fatty liver disease, and barth syndrome. The molecule is a stabilizing cytochrome oxidase, apoptosis, stabilizing mitochondrial structure that impacts tangier disease and diabetic heart disease.	CCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCC(C)CC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCC(C)CC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC
The molecule is tumor treatment.	Cc1cccc2c(OC(=O)N(CCOCCO)CCN(C)C(=O)OCc3ccc(NC(=O)CNC(=O)C(NC(=O)OCN4C(=O)C=CC4=O)C(C)C)cc3)cc3c(c12)CCN3C(=O)c1cc2cc(NC(=O)c3ccc(O)cc3)cnc2[nH]1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, apoptosis that impacts barth syndrome and diabetic heart disease. The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts non-alcoholic fatty liver disease, tangier disease, and aging.	CCCCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=CC/C=CC/C=CCCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a liquid crystal.	CCCCCC1CCC(CCC2CCC(C(CO)COC3CCCCO3)CC2)CC1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a stabilizing mitochondrial structure and a stabilizing cytochrome oxidase that impacts barth syndrome, non-alcoholic fatty liver disease, and aging. The molecule is a proton trap for oxidative phosphorylation, cholesterol translocation, apoptosis that impacts tangier disease and diabetic heart disease.	CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=CC/C=CC/C=CCCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC
The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, apoptosis that impacts barth syndrome and non-alcoholic fatty liver disease. The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts diabetic heart disease, aging, and tangier disease.	CCCCC/C=C\C/C=C\CCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=CC/C=CC/C=CCCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC
The molecule is a nutrient that affects both breast cancer and cervical cancer, and also impacts ulcerative colitis and atherosclerosis.	CCCCC/C=C\C/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCC/C=C\CCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC
When heated to decomposition it emits toxic fumes of nitroxides. The molecule has both a Slightly bitter taste and a Odorless or almost odorless.	CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
The molecule is a energy storage and a membrane stabilizer that impacts metabolic syndrome, thyroxine treatment, atherosclerosis, and pancreatitis. The molecule is a nutrient and fat storage, and it impacts obesity. The molecule is a inflammatory and a energy source, with effects on cancer and impacts on cardiovascular disease.	CCCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCC(C)C	CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCC(C)C
The molecule is a inflammatory, membrane stabilizer, nutrient, fat storage that impacts pancreatitis and metabolic syndrome. The molecule is a energy storage and energy source, and it impacts cardiovascular disease. The molecule is a thyroxine treatment that impacts obesity, atherosclerosis, and cancer.	CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCCC(C)C	CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCC(C)C
The molecule is a orexin type 2 receptor agonist.	COC(=O)N1CCCC(NS(C)(=O)=O)C1Cc1cccc(-c2cccc(OC)c2)c1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts diabetic heart disease, non-alcoholic fatty liver disease, and aging. The molecule is a proton trap for oxidative phosphorylation, apoptosis, stabilizing cytochrome oxidase that impacts barth syndrome and tangier disease.	CCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC
The molecule is a stabilizing cytochrome oxidase and a emulsifier, impacting both tangier disease and diabetic heart disease. The molecule is a stabilizing mitochondrial structure, nutritional supplement, food additive, proton trap for oxidative phosphorylation that impacts barth syndrome. The molecule is a energy storage, a energy source, and a apoptosis, and it impacts non-alcoholic fatty liver disease. The molecule is a membrane stabilizer, a cholesterol translocation, and a surfactant, it impacts aging and is smooth.	CCC(C)CCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a cancer treatment.	NC(=S)NC(=O)Cc1cccc(-c2cccc(F)c2)c1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a nutrient that impacts non-alcoholic fatty liver disease, alzheimer's disease, parkinson's disease, and diabetes mellitus type 2.	CCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCC1OC1C/C=C\C/C=C\C/C=C\CCCCC)COP(=O)(O)OCCN	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCCCC
The molecule is a apoptosis, cholesterol translocation, stabilizing cytochrome oxidase that impacts aging and barth syndrome. The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, diabetic heart disease, and tangier disease.	CCCCC/C=C\C/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCC/C=C\CCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a cholesterol translocation that impacts aging, non-alcoholic fatty liver disease, tangier disease, and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, apoptosis, stabilizing mitochondrial structure that impacts barth syndrome.	CCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC(C)CC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a nutrient, surfactant, energy source, herb, and woody. The molecule is a energy storage, emulsifier, membrane stabilizer, flavoring agent, and herbal.	CC(CO)CC(=O)CC1(C)CCC(c2ccoc2)O1	CCCCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](N)C(=O)O)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCCCC
The molecule is a nutrient that impacts alzheimer's disease, parkinson's disease, non-alcoholic fatty liver disease, and diabetes mellitus type 2.	CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCC/C=C\C/C=C\C=C\[C@@H](O)C/C=C\CCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCCCC
The molecule is a proteasome inhibitor.	CC(C)CC(NC(=O)C(N)COC(F)F)C(=O)O	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is anti tumor.	CCc1cc2c(cc1N1CCN(C(=O)CCOCCOCCC(=O)NC(C(=O)N3CC(O)CC3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a proton trap for oxidative phosphorylation and a apoptosis that impacts diabetic heart disease, aging, and tangier disease. The molecule is a stabilizing cytochrome oxidase, stabilizing mitochondrial structure, cholesterol translocation that impacts barth syndrome and non-alcoholic fatty liver disease.	CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=CC/C=CC/C=CCCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC
The molecule is a nutrient, a flavoring agent, spicy, cinnamon, and floral.	OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](N)C(=O)O)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCCCC
The molecule is a proton trap for oxidative phosphorylation and a stabilizing cytochrome oxidase that impacts diabetic heart disease, non-alcoholic fatty liver disease, and tangier disease. The molecule is a apoptosis, cholesterol translocation, stabilizing mitochondrial structure that impacts barth syndrome and aging.	CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=CC/C=CC/C=CCCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC
The molecule is a type 2 diabetes treatment, a jnk inhibitor, and obesity treatment.	CC(=O)N1CCC(NC(=O)c2cccc3cnc(NC4CCC(O)CC4)nc23)CC1	CC(C)(C)OC(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)cc1
The molecule is a electronic device, organic electroluminescent material, and electroluminescent compound.	c1ccc(-n2c3ccccc3c3cc(-c4ccc(N(c5ccc(-c6cccc(-c7ccc8ccccc8c7)c6)cc5)c5ccc(-c6ccc7c(c6)sc6ccccc67)cc5)cc4)ccc32)cc1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
The molecule is a cholesterol translocation, apoptosis, proton trap for oxidative phosphorylation that impacts diabetic heart disease and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure and a stabilizing cytochrome oxidase that impacts barth syndrome, aging, and tangier disease.	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=C\C/C=C\C/C=C\CC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCC/C=C\C/C=C\C/C=C\CC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC
The molecule is a organic electroluminescent member of the electroluminescent class.	Cc1cccc(N(c2ccc3cc4c5cccc6c7cc8ccc(N(c9cccc(C)c9)C9CC=Cc%10c9oc9ccccc%109)cc8cc7n(c4cc3c2)c56)c2cccc3c2oc2ccccc23)c1	c1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a apoptosis, stabilizing mitochondrial structure, cholesterol translocation that impacts non-alcoholic fatty liver disease and tangier disease. The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation that impacts barth syndrome, aging, and diabetic heart disease.	CCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC(C)CC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC(C)C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCCCC
It impacts copd treatment.	C=C1c2cc(F)ccc2SN1c1ccc(Cl)cc1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation that impacts barth syndrome, aging, and non-alcoholic fatty liver disease. The molecule is a apoptosis, stabilizing mitochondrial structure, stabilizing cytochrome oxidase that impacts diabetic heart disease and tangier disease.	CCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC(C)CC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCC(C)C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a energy source that impacts celiac disease, renal cell carcinoma, and cardiovascular disease. It has an effect on breast cancer, and impacts diabetes mellitus type 2, heart failure, and inflammatory bowel disease.	CCC=CCC(O)C(O)C=CC(O)CCCCCCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, stabilizing cytochrome oxidase that impacts barth syndrome and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation and a apoptosis that impacts aging, non-alcoholic fatty liver disease, and tangier disease.	CCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC
The molecule is a hiv treatment and is anti retroviral.	COc1ccc(-c2nc3c(C(=O)N4CCN(C(CO)c5cccc(F)c5)CC4C)cnn3c(C(F)(F)F)c2C)cc1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
When heated to decomposition it emits highly toxic fumes of sulfur and nitrogen oxides. The molecule has Aromatic odor.	CCCCN(CC)C(=O)SCCC	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
The molecule is a nutrient that impacts diabetes mellitus type 2, non-alcoholic fatty liver disease, parkinson's disease, and alzheimer's disease.	CCCCC/C=C\C/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCC/C=C\C/C=C\CC1OC1C/C=C\CCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCCCC
The molecule is a kinase inhibitor and belongs to the cancer treatment class of molecules.	CN1CC2CCC(C1)N2Cc1ccc(Nc2ncc(F)c(-c3cc(F)c4nc5n(c4c3)C(C)(C)CC5)n2)nc1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
The molecule is a member of the thyroxine treatment class and affects both pancreatitis and atherosclerosis. The molecule is a nutrient and a fat storage, impacting both cardiovascular disease and metabolic syndrome.	CCCCCCCC/C=C\CCCCCCCCCC(=O)OC[C@@H](COCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COC(=O)CCCCCCCCC/C=CCCCCCCCC)OC(=O)CCCCCCCCC/C=CCCCCCCCC
The molecule is a liquid crystal.	C=C(C)C(=O)OCCCc1cc(-c2ccc(OC(=O)CCc3ccc(CCCCCC)cc3)cc2)ccc1OCC(COC(=O)C(=C)C)(COC(=O)C(C)=O)COC(=O)C(C)=O	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a nutrient.	CCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\[C@@H](O)CCCC)COP(=O)(O)OC[C@H](N)C(=O)O	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](N)C(=O)O)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCCCC
The molecule is a energy storage, energy source, membrane stabilizer, inflammatory that has an effect on lipotoxicity and impacts metabolic syndrome.	CCCCCCCCCCCCCCCCCCCC(=O)O[C@@H](CO)COC(=O)CCCCCCCCCCC(C)C	CCC(C)CCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCC(C)C
The molecule is a rock inhibitor.	CC(C)(C)c1ncc2cc(C(C)(C)C)[nH]c2n1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccc(-c6ccccc6)cc6)cc4)cc4)cc3)cc2)cc1
The molecule is a thyroxine treatment that impacts both pancreatitis and cardiovascular disease. The molecule is a nutrient and a fat storage, impacting both metabolic syndrome and atherosclerosis.	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)COC(=O)CCCCCCC/C=C\C/C=C\CCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COC(=O)CCCCCCCCC/C=CCCCCCCCC)OC(=O)CCCCCCCCC/C=CCCCCCCCC
The molecule is a proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, stabilizing cytochrome oxidase that impacts aging and diabetic heart disease. The molecule is a apoptosis and a cholesterol translocation that impacts barth syndrome, tangier disease, and non-alcoholic fatty liver disease.	CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCC
The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation that impacts tangier disease, diabetic heart disease, and aging. The molecule is a apoptosis, stabilizing cytochrome oxidase, cholesterol translocation that impacts non-alcoholic fatty liver disease and barth syndrome.	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a nutrient that impacts alzheimer's disease, diabetes mellitus type 2, parkinson's disease, and non-alcoholic fatty liver disease.	CCCCC/C=C\C=C\C(=O)CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)O/C=C/CCCCCCCC/C=C\CCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCCCC
The molecule is a apoptosis and a cholesterol translocation that impacts tangier disease, diabetic heart disease, and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts aging and barth syndrome.	CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC(C)CC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a stabilizing cytochrome oxidase, stabilizing mitochondrial structure, cholesterol translocation that impacts tangier disease and diabetic heart disease. The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts barth syndrome, non-alcoholic fatty liver disease, and aging.	CCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC)OC(=O)CCCCCCCCC(C)CC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCCCC
The molecule is a membrane stabilizer, fat storage, inflammatory that impacts obesity, atherosclerosis, and cardiovascular disease. The molecule is a nutrient and energy source, and it impacts pancreatitis. The molecule is a energy storage that affects cancer by impacting both thyroxine treatment and metabolic syndrome.	CCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCC(C)C	CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)C
The molecule is a nutrient that impacts both metabolic syndrome and cardiovascular disease. The molecule is a fat storage and belongs to the thyroxine treatment class of molecules, impacting both pancreatitis and atherosclerosis.	CCCCC/C=C\C/C=C\CCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COC(=O)CCCCCCCCC/C=CCCCCCCCC)OC(=O)CCCCCCCCC/C=CCCCCCCCC
The molecule is a energy source, inflammatory, nutrient, energy storage that impacts cardiovascular disease and obesity. The molecule is a fat storage that impacts both cancer and pancreatitis. The molecule is a membrane stabilizer and a thyroxine treatment, impacting both metabolic syndrome and atherosclerosis.	CCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCC(C)C	CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C
The molecule is a magl inhibitor.	CC1C(OCc2c(F)cccc2C(F)(F)F)CN1OC(=O)C(F)(F)F	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a dyslipidemia treatment and is ppar modulator.	O=C(O)COc1ccc(SCC=C(c2ccccc2C(F)(F)F)c2ccccc2C(F)(F)F)cc1I	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation, it impacts non-alcoholic fatty liver disease, and is smooth. The molecule is a food additive, surfactant, membrane stabilizer that impacts tangier disease and barth syndrome. The molecule is a stabilizing cytochrome oxidase, a emulsifier, and a energy storage, and it impacts aging. The molecule is a stabilizing mitochondrial structure, energy source, nutritional supplement, apoptosis that impacts diabetic heart disease.	CCCCCC/C=C\C=C/CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCC(C)C)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCC(C)C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a nutrient that affects both cervical cancer and breast cancer, and also impacts ulcerative colitis and atherosclerosis.	CC/C=C/C/C=C/C=C/C(O)CCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a stabilizing mitochondrial structure, apoptosis, cholesterol translocation, proton trap for oxidative phosphorylation that impacts tangier disease. The molecule is a stabilizing cytochrome oxidase that impacts barth syndrome, diabetic heart disease, non-alcoholic fatty liver disease, and aging.	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC
The molecule is a kinase inhibitor.	CNc1cc(Oc2ccc3c(C(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(CN5CCOCC5)c4)cccc3c2)ncn1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
When heated to decomposition it emits acrid smoke and irritating fumes.	CC12C(=O)OC(=O)C1(C)C1CCC2O1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
The molecule is a cholesterol translocation and a apoptosis that impacts barth syndrome, non-alcoholic fatty liver disease, and tangier disease. The molecule is a proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, stabilizing cytochrome oxidase that impacts diabetic heart disease and aging.	CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCCCC
The molecule is a emulsifier that impacts tangier disease, aging, and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure, cholesterol translocation, proton trap for oxidative phosphorylation, surfactant that impacts barth syndrome. The molecule is a membrane stabilizer, a food additive, and a energy storage, and it impacts diabetic heart disease. The molecule is a nutritional supplement, apoptosis, energy source, stabilizing cytochrome oxidase, and smooth.	CCC(C)CCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)CC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a membrane stabilizer, a nutritional supplement, and a energy source, and it impacts tangier disease. The molecule is a food additive, a energy storage, and a emulsifier, it impacts aging and is smooth. The molecule is a stabilizing mitochondrial structure and a stabilizing cytochrome oxidase, impacting both non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a surfactant, proton trap for oxidative phosphorylation, cholesterol translocation, apoptosis that impacts barth syndrome.	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts barth syndrome, non-alcoholic fatty liver disease, and aging. The molecule is a stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, cholesterol translocation that impacts diabetic heart disease and tangier disease.	CC/C=C\C/C=C\C/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=CC/C=CC/C=CCCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC
The molecule is a energy source, inflammatory, nutrient that impacts obesity, atherosclerosis, and metabolic syndrome. The molecule is a energy storage that impacts both pancreatitis and cardiovascular disease. The molecule is a membrane stabilizer and fat storage, belonging to the thyroxine treatment class of molecules, with an effect on cancer.	CCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCC(C)C	CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCC(C)C
The molecule is a energy source, energy storage, nutrient that impacts atherosclerosis, cancer, and cardiovascular disease. The molecule is a member of the thyroxine treatment class and affects both obesity and pancreatitis. The molecule is a membrane stabilizer, a fat storage, and a inflammatory, and it impacts metabolic syndrome.	CCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCC(C)CC	CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C
The molecule is a stabilizing cytochrome oxidase, a energy storage, and a cholesterol translocation, and it impacts barth syndrome. The molecule is a membrane stabilizer, proton trap for oxidative phosphorylation, energy source that impacts aging and tangier disease. The molecule is a nutritional supplement, a surfactant, and a emulsifier, and it impacts diabetic heart disease. The molecule is a apoptosis, a stabilizing mitochondrial structure, and a food additive, it impacts non-alcoholic fatty liver disease and is smooth.	CCC(C)CCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
It impacts insulin resistance.	CCCCCC/C=C\CCCCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](N)C(=O)O)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCCCC
The molecule is both a protease inhibitor and a thrombin inhibitor.	CCC(O)Oc1cc(C)cc(OS(=O)(=O)c2cccnc2)c1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a apoptosis, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease and aging. The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation that impacts tangier disease, barth syndrome, and diabetic heart disease.	CCCCCC/C=C\C=C/CCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a apoptosis and a cholesterol translocation that impacts barth syndrome, aging, and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts diabetic heart disease and tangier disease.	CCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
It has an effect on stomach cancer, and impacts diabetes mellitus, seizure, and alzheimer's disease. It influences both breast cancer and colorectal cancer, as well as affecting parkinson's disease and cardiovascular disease.	CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CC[C@@H](O)CC)COP(=O)(O)O[C@H]1C(O)C(O)C(O)[C@@H](OP(=O)(O)O)C1O	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)O[C@H]1C(O)C(O)C(O)[C@@H](OP(=O)(O)O)C1O)OC(=O)CCC/C=CC/C=CC/C=CC/C=CCCCCC
The molecule is a nutrient that affects cancer by impacting cardiovascular disease, pancreatitis, obesity, and metabolic syndrome. The molecule is a energy source, a energy storage, and a inflammatory. The molecule is a membrane stabilizer and a fat storage, impacting both atherosclerosis and thyroxine treatment.	CCCCCCCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC)COC(=O)CCCCCCCCC(C)CC	CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)C
The molecule is cancer treatment.	Cc1[nH]cc(Br)c(=O)c1C(=O)O	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a akt inhibitor and belongs to the cancer treatment class of molecules.	Cc1nc(N2CCOCC2)cc(=O)[nH]1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
The molecule is a prmt5 inhibitor.	CCN(C)c1nc(NC2COC2)cc(C(=O)O)n1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
It belongs to the tumor treatment class of molecules.	CCCN(Cc1cc2c(cc1C)OCO2)C(=O)C1OC(=O)OC1CC=O	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
The molecule is a protein kinase inhibitor.	CN(C)CCOc1ccc(Nc2ncc3scc(-c4cccc(NS(C)(=O)=O)c4)c3n2)cn1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a stabilizing cytochrome oxidase, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts tangier disease and aging. The molecule is a cholesterol translocation and a apoptosis that impacts diabetic heart disease, barth syndrome, and non-alcoholic fatty liver disease.	CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC(C)CC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCC
The molecule is a inflammatory, fat storage, nutrient that impacts metabolic syndrome, pancreatitis, and obesity. The molecule is a energy storage that impacts both cancer and cardiovascular disease. The molecule is a energy source and a membrane stabilizer, impacting both thyroxine treatment and atherosclerosis.	CCC(C)CCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCC(C)C	CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C
The molecule is a nutrient.	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCCCCCC[C@@H](O)[C@H](O)C/C=C\CCCCC)COP(=O)(O)OC[C@H](N)C(=O)O	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](N)C(=O)O)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCCCC
The molecule is a factor xa inhibitor that is anti coagulant and anti coagulant agent.	NC(=O)CNC(=O)c1ccc(N2C=NCCC2)cc1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts aging, tangier disease, and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, cholesterol translocation that impacts non-alcoholic fatty liver disease and barth syndrome.	CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCCCC
The molecule is a cholesterol translocation, apoptosis, stabilizing cytochrome oxidase that impacts diabetic heart disease and aging. The molecule is a proton trap for oxidative phosphorylation and a stabilizing mitochondrial structure that impacts tangier disease, non-alcoholic fatty liver disease, and barth syndrome.	CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a dielectric.	CCCc1ccc(-c2ccc(CCC(F)(F)Oc3ccc(F)c(F)c3)cc2)c(F)c1F	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
The molecule is a nutrient that impacts non-alcoholic fatty liver disease, diabetes mellitus type 2, parkinson's disease, and alzheimer's disease.	CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCC(=O)/C=C/C=C\C/C=C\C/C=C\CCCCC)COP(=O)(O)OCCN	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCCCC
The molecule is a inflammatory, nutrient, fat storage that impacts cardiovascular disease, pancreatitis, and metabolic syndrome. The molecule is a thyroxine treatment and energy storage, and it impacts atherosclerosis. The molecule is a energy source and a membrane stabilizer, impacting both cancer and obesity.	CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C	CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCC(C)C
The molecule is a nutrient.	CCCCCCCC/C=C\CCCCCCCCCCCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C=C\C(=O)CCCCC)COP(=O)(O)OC[C@H](N)C(=O)O	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](N)C(=O)O)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCCCC
The molecule is a monoamine reuptake inhibitor and is anti depressant.	CCCCC1(C(=O)c2cc3cc[nH]c3c(F)c2F)CCNC1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a membrane stabilizer, energy source, energy storage that impacts atherosclerosis, obesity, and metabolic syndrome. The molecule is a inflammatory that impacts both cardiovascular disease and pancreatitis. The molecule is a fat storage and nutrient, thyroxine treatment, and has an effect on cancer.	CCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)CC)COC(=O)CCCCCCCCCC(C)C	CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)C
It impacts neurological treatment.	COC(=O)N1CCC(C2(O)OCCO2)C(=O)C1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation that impacts tangier disease, non-alcoholic fatty liver disease, and diabetic heart disease. The molecule is a stabilizing mitochondrial structure, apoptosis, stabilizing cytochrome oxidase that impacts barth syndrome and aging.	CCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCC(C)CC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCC
It impacts cancer treatment.	Nc1nc(NC2Cc3ccccc3N(S(=O)(=O)c3ccc(Oc4ccccc4)cc3)C2)c2cn[nH]c2n1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a nutrient that impacts parkinson's disease, diabetes mellitus type 2, alzheimer's disease, and non-alcoholic fatty liver disease.	CCCCC/C=C\C/C=C\C/C=C\CC1OC1CCCC(=O)O[C@H](CO/C=C/CCCCCCCCCCCCCC)COP(=O)(O)OCCN	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCCCC
The molecule is a apoptosis, stabilizing mitochondrial structure, stabilizing cytochrome oxidase that impacts aging and barth syndrome. The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, tangier disease, and diabetic heart disease.	CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a energy storage and a fat storage that impacts metabolic syndrome, obesity, cancer, and cardiovascular disease. The molecule is a membrane stabilizer, a inflammatory, and thyroxine treatment. The molecule is a energy source and a nutrient, impacting both pancreatitis and atherosclerosis.	CCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)CC	CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, stabilizing cytochrome oxidase that impacts diabetic heart disease and barth syndrome. The molecule is a proton trap for oxidative phosphorylation and a apoptosis that impacts aging, non-alcoholic fatty liver disease, and tangier disease.	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)O[C@H](COC(=O)CCCCCCCCC/C=C\C/C=C\C/C=C\CC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC
The molecule is a apoptosis, cholesterol translocation, stabilizing cytochrome oxidase that impacts tangier disease and aging. The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, barth syndrome, and diabetic heart disease.	CCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCCCC
The molecule is a organic optoelectronic device and is optoelectronic.	C=CC=Cc1[nH]c2cc(-c3ccccc3)ccc2c1C	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
The molecule is a nutrient.	C=CCSSC(CC)S(C)=O	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](N)C(=O)O)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCCCC
The molecule is a proton trap for oxidative phosphorylation and a energy storage, impacting both aging and barth syndrome. The molecule is a food additive, a emulsifier, and a surfactant, it impacts non-alcoholic fatty liver disease and is smooth. The molecule is a stabilizing cytochrome oxidase, a stabilizing mitochondrial structure, and a nutritional supplement, and it impacts diabetic heart disease. The molecule is a membrane stabilizer, energy source, apoptosis, cholesterol translocation that impacts tangier disease.	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a cholesterol translocation, a stabilizing cytochrome oxidase, and a nutritional supplement, and it impacts aging. The molecule is a emulsifier, energy source, membrane stabilizer, energy storage that impacts non-alcoholic fatty liver disease. The molecule is a apoptosis, a proton trap for oxidative phosphorylation, and a food additive, and it impacts diabetic heart disease. The molecule is a stabilizing mitochondrial structure and a surfactant, which impacts both tangier disease and barth syndrome, and is characterized as smooth.	CCCCCC/C=C\C=C/CCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCC(C)C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a cancer treatment.	CCc1cc(-c2ccccc2)nnc1Nc1ccc(Oc2ncccc2-c2ccnc(NCCCN3CCCCC3)n2)cc1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, apoptosis that impacts diabetic heart disease and aging. The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts non-alcoholic fatty liver disease, barth syndrome, and tangier disease.	CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=CC/C=CC/C=CCCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC
The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease, barth syndrome, and aging. The molecule is a proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, apoptosis that impacts tangier disease and diabetic heart disease.	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is anti retroviral.	C=C(C)COC(C)C(NC(=O)OC(C)(C)C)C(=O)OC	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a hcv inhibitor and is anti viral.	CCOc1ccc2c(C(C)=O)c(-c3ccc(NC(=O)NC4CCC4)cc3)n(C3CCC3)c2c1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
The molecule is a nutrient that impacts non-alcoholic fatty liver disease, alzheimer's disease, parkinson's disease, and diabetes mellitus type 2.	CCCCC/C=C\C[C@@H](O)[C@H](O)CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)O/C=C/CCCCCCCC/C=C\CCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCCCC
The molecule is a stabilizing cytochrome oxidase, apoptosis, proton trap for oxidative phosphorylation that impacts aging and tangier disease. The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts diabetic heart disease, barth syndrome, and non-alcoholic fatty liver disease.	CCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC)OC(=O)CCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCCCC
The molecule is inflammation treatment.	CC1CCCC(O)(C#Cc2nc(N)c3ncn(C4OC(C(=O)NC5CC5)C(O)C4O)c3n2)C1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a anti viral that impacts hiv treatment.	Nc1ncc2ncn(C3COC(CO)O3)c2n1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
The molecule is a cholesterol translocation and a apoptosis that impacts diabetic heart disease, barth syndrome, and aging. The molecule is a proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease and tangier disease.	CC/C=C\C/C=C\C/C=C\CCCCCCCCCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=CC/C=CC/C=CCCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC
The molecule is a apoptosis and a stabilizing mitochondrial structure that impacts barth syndrome, non-alcoholic fatty liver disease, and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, proton trap for oxidative phosphorylation that impacts aging and tangier disease.	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCC/C=C\C/C=C\C/C=C\CC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a energy storage, a emulsifier, a energy source, and smooth. The molecule is a stabilizing mitochondrial structure, cholesterol translocation, surfactant, apoptosis that impacts aging. The molecule is a proton trap for oxidative phosphorylation and a food additive, impacting both tangier disease and non-alcoholic fatty liver disease. The molecule is a membrane stabilizer, stabilizing cytochrome oxidase, nutritional supplement that impacts diabetic heart disease and barth syndrome.	CCC(C)CCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a cholesterol translocation and a apoptosis that impacts diabetic heart disease, aging, and barth syndrome. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts tangier disease and non-alcoholic fatty liver disease.	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCC/C=C\C/C=C\C/C=C\CC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a anti inflammatory.	COc1ccc(C2=NC(S)(c3ccc(OC)cc3)N=C2)cc1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a nutrient that impacts diabetes mellitus type 2, non-alcoholic fatty liver disease, parkinson's disease, and alzheimer's disease.	CCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCCC(O)C(O)C/C=C\C/C=C\C/C=C\CCCCC)COP(=O)(O)OCCN	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCCCC
The molecule is a apoptosis, cholesterol translocation, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts aging. The molecule is a stabilizing mitochondrial structure that impacts tangier disease, diabetic heart disease, non-alcoholic fatty liver disease, and barth syndrome.	CCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC(C)CC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCCC(C)C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCCCC
The molecule is a proton trap for oxidative phosphorylation, apoptosis, stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease and barth syndrome. The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts aging, diabetic heart disease, and tangier disease.	CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCC(C)CC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=CC/C=CC/C=CCCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a energy source and nutrient, belonging to the thyroxine treatment class of molecules, with effects on cancer and impacts on both metabolic syndrome and obesity. The molecule is a membrane stabilizer that impacts both cardiovascular disease and pancreatitis. The molecule is a inflammatory, a fat storage, and a energy storage, and it impacts atherosclerosis.	CCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCCC(C)C	CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C
The molecule is a nutrient that impacts cervical cancer, ulcerative colitis, breast cancer, and atherosclerosis.	CCCc1oc(CCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C=C\[C@H](O)CC)c(C)c1C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a nutrient, inflammatory, fat storage that impacts obesity, metabolic syndrome, and cardiovascular disease. The molecule is a energy source that affects cancer by impacting pancreatitis. The molecule is a membrane stabilizer and a energy storage, impacting both atherosclerosis and thyroxine treatment.	CCC(C)CCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCCCCC(C)C	CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)C
The molecule is a protein kinase inhibitor and belongs to the proliferative disorder treatment class of molecules.	Cc1ccc(-c2nn(C(C)(C)CNS(=O)(=O)c3ccccc3)c3ncnc(N)c23)cc1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
The molecule is a membrane stabilizer, a signalling molecule, and a nutrient. The molecule is a energy source, surfactant, emulsifier, energy storage.	C=C(C)C(CC)CCC(C)C1CCC2C3CC=C4CC(OC5OC(CO)C(O)C(O)C5O)CCC4(C)C3CCC12C	CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](N)C(=O)O)OC(=O)CCCCCCCCCCCCCCC(C)C
The molecule is a membrane stabilizer, nutrient, energy source, energy storage.	CCCCCCCCCCC1OC(C(O)CCC(O)C2CCC(CCCCCCCC(O)CC3=CC(C)OC3=O)O2)CCC1O	CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](N)C(=O)O)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCCCC
The molecule is a stabilizing mitochondrial structure and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, barth syndrome, and diabetic heart disease. The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, apoptosis that impacts aging and tangier disease.	CCCCCC/C=C\C=C/CCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCC(C)CC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCCCC
The molecule is a pde4 inhibitor and belongs to both the cardiovascular treatment and inflammatory treatment classes of molecules.	CCOC(OCC)(OP=O)c1cc2sc(NC(=O)OC(C)(C)C)nc2c(-c2cccc([N+](=O)[O-])c2)c1OC	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a anti viral.	O=c1c2cc(F)ccc2[se]n1-c1ccc2c(c1)OCO2	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is both a rock inhibitor and a kinase inhibitor.	C=CC=CC=COCC(=O)OCCC	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts diabetic heart disease, non-alcoholic fatty liver disease, and aging. The molecule is a cholesterol translocation, stabilizing mitochondrial structure, stabilizing cytochrome oxidase that impacts tangier disease and barth syndrome.	CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC
It belongs to both the apj agonist and cardiovascular treatment classes of molecules.	Cc1cnc(CC(C)SN)nc1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a nutrient.	COC1C=C2CC(O)CCC2(C)C2CCC3(C)C(C(C)C(O)CC(C)C(C)C)CCC3C12	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](N)C(=O)O)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCCCC
The molecule is anti viral.	O=C(C=Cc1ccccc1)Nc1nnc(NCc2ccc(Cl)c(Cl)c2)s1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a nutrient that impacts both thyroxine treatment and metabolic syndrome. The molecule is a fat storage that impacts atherosclerosis, pancreatitis, and cardiovascular disease.	CCCCCCCC/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COC(=O)CCCCCCCCC/C=CC/C=CC/C=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC
The molecule is a energy storage, inflammatory, energy source, membrane stabilizer that impacts obesity and atherosclerosis. The molecule is a fat storage that affects cancer by impacting metabolic syndrome. The molecule is a nutrient and a thyroxine treatment, impacting both cardiovascular disease and pancreatitis.	CCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC	CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)C
It impacts metabolic syndrome, atherosclerosis, and cardiovascular disease. The molecule is a thyroxine treatment, a fat storage, and a nutrient, and it impacts pancreatitis.	CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COC(=O)CCCCCCCCC/C=CCCCCCCCC)OC(=O)CCCCCCCCC/C=CCCCCCCCC
The molecule is a apoptosis, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, stabilizing cytochrome oxidase that impacts barth syndrome. The molecule is a cholesterol translocation that impacts non-alcoholic fatty liver disease, tangier disease, aging, and diabetic heart disease.	CCCCCC/C=C\C=C/CCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCCCC
It impacts colorectal cancer, parkinson's disease, stomach cancer, and seizure. It impacts diabetes mellitus, alzheimer's disease, breast cancer, and cardiovascular disease.	CCCCCC/C=C\CCCCCCCC(=O)OC[C@@H]1COP(=O)(O)O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CCCCCCC(=O)O1)C(=O)C[C@@H](O)[C@H](/C=C/[C@@H](O)CCCCC)[C@@H](O)[C@H]2O	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)O[C@H]1C(O)C(O)C(O)[C@@H](OP(=O)(O)O)C1O)OC(=O)CCC/C=CC/C=CC/C=CCCCC
It belongs to the anti fungal class of molecules.	CC(O)(CO)OCCC(O)CCc1ccc(F)cc1F	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts diabetic heart disease, barth syndrome, and tangier disease. The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease and aging.	CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC)OC(=O)CCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCCCC
The molecule is a organic light-emitting diode that affects both light emission and low driving voltage and is characterized as light-emitting.	CC1(C)c2ccccc2-c2nc(-c3cccc(C#N)c3)c(-n3c4cc5ccccc5cc4c4ccc5ccccc5c43)nc21	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
The molecule is a stabilizing mitochondrial structure and a apoptosis that impacts aging, diabetic heart disease, and non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation, cholesterol translocation, stabilizing cytochrome oxidase that impacts tangier disease and barth syndrome.	CCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCC(C)C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC
The molecule is a stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, apoptosis, cholesterol translocation that impacts non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase that impacts aging, diabetic heart disease, tangier disease, and barth syndrome.	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=CC/C=CC/C=CCCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is cardiovascular treatment.	Cn1c2c(c3ccccc31)CC(C(=O)OC(=O)CCl)NC2c1ccc2c(c1)OCO2	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a inflammatory that impacts pancreatitis, cardiovascular disease, obesity, cancer, and metabolic syndrome. The molecule is a membrane stabilizer that impacts both thyroxine treatment and atherosclerosis. The molecule is a energy storage, energy source, fat storage, nutrient.	CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC)COC(=O)CCCCCCCCCCC(C)CC	CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C
The molecule is a nutrient that impacts both cardiovascular disease and metabolic syndrome. The molecule is a fat storage and thyroxine treatment, impacting both atherosclerosis and pancreatitis.	CC/C=C\C/C=C\C/C=C\C/C=C\CCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COC(=O)CCCCCCCCC/C=CC/C=CC/C=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC
The molecule is hepatitis b treatment and anti viral.	Cc1cc(NC(=O)N2CCC(=O)C3CCCCC32)ccc1F	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, apoptosis that impacts non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase and a stabilizing mitochondrial structure that impacts aging, tangier disease, and barth syndrome.	CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, apoptosis, cholesterol translocation that impacts aging. The molecule is a proton trap for oxidative phosphorylation that impacts barth syndrome, non-alcoholic fatty liver disease, diabetic heart disease, and tangier disease.	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a anti cancer.	COC(C=O)n1nnc(CCC(NC(=O)OCc2ccccc2)C(=O)O)n1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a nutrient, energy source, surfactant, membrane stabilizer, emulsifier, energy storage.	Cc1cocc2c(C=O)ccc1-2	CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](N)C(=O)O)OC(=O)CCCCCCCCCCCCCCCCC(C)C
The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts tangier disease. The molecule is a apoptosis that impacts diabetic heart disease, non-alcoholic fatty liver disease, aging, and barth syndrome.	CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)CC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a cholesterol translocation, apoptosis, stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease and barth syndrome. The molecule is a proton trap for oxidative phosphorylation and a stabilizing mitochondrial structure that impacts diabetic heart disease, tangier disease, and aging.	CCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCC(C)C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=CC/C=CC/C=CCCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a nutrient that affects cervical cancer by impacting atherosclerosis, breast cancer, and ulcerative colitis.	CCCCC[C@H](O)/C=C/[C@H]1OC(O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCc1oc(CCC)c(C)c1C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a membrane stabilizer, energy source, energy storage, fat storage that impacts pancreatitis and cardiovascular disease. The molecule is a inflammatory that affects cancer by impacting metabolic syndrome. The molecule is a nutrient and thyroxine treatment, impacting both obesity and atherosclerosis.	CC(C)CCCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCC(C)C	CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)C
The molecule is a nutrient and energy source, belonging to the thyroxine treatment class of molecules, and impacts obesity, pancreatitis, and metabolic syndrome. The molecule is a membrane stabilizer that impacts both atherosclerosis and cancer. The molecule is a inflammatory, a fat storage, and a energy storage, and it impacts cardiovascular disease.	CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)C	CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCC(C)C
The molecule is a anti viral.	CCCCC(=O)OC1C(CO)OC(O)C(O)C1O	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a apoptosis, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts barth syndrome and diabetic heart disease. The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, tangier disease, and aging.	CCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCC(C)CC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCCCC
The molecule is a kinase inhibitor and is cancer treatment.	COc1ccc(F)cc1-c1ccnc2[nH]c(C3=CC(CO)NC3)cc12.Cl.Cl	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
The molecule is a energy source, fat storage, nutrient that impacts metabolic syndrome, pancreatitis, and thyroxine treatment. The molecule is a membrane stabilizer that impacts both cardiovascular disease and obesity. The molecule is a inflammatory and a energy storage, with effects on cancer and impacts on atherosclerosis.	CCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCC(C)C	CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)C
The molecule is a apoptosis, cholesterol translocation, stabilizing cytochrome oxidase that impacts barth syndrome and tangier disease. The molecule is a proton trap for oxidative phosphorylation and a stabilizing mitochondrial structure that impacts aging, diabetic heart disease, and non-alcoholic fatty liver disease.	CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCCCC
The molecule is a stabilizing mitochondrial structure and a stabilizing cytochrome oxidase that impacts tangier disease, non-alcoholic fatty liver disease, and barth syndrome. The molecule is a apoptosis, cholesterol translocation, proton trap for oxidative phosphorylation that impacts diabetic heart disease and aging.	CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC(C)CC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC
The molecule is a nutrient.	CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](N)C(=O)O)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CC(O)CCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](N)C(=O)O)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCCCC
It impacts alzheimer's disease, seizure, stomach cancer, and parkinson's disease. It has an effect on breast cancer, and impacts cardiovascular disease, colorectal cancer, and diabetes mellitus.	CCCCCCCC/C=C\CCCCCCCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C=C\[C@@H](O)CC)COP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1O	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)O[C@H]1C(O)C(O)C(O)[C@@H](OP(=O)(O)O)C1O)OC(=O)CCC/C=CC/C=CC/C=CCCCC
The molecule is anti inflammatory.	CC1CC2C3CCC4CC(=O)CCC4(C)C3=CCC2(C)C1(O)C(=O)CO	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a jak inhibitor, immunomodulator, protein tyrosine kinase inhibitor, protein kinase inhibitor and belongs to the autoimmune disease treatment class of molecules.	N#CCc1ccc(CC(=O)N2CCN(c3ncnc4[nH]cc(Cl)c34)CC23CC3)cc1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
The molecule is a nutrient.	CC(=O)c1c(O)cc(O)c(C2OC(COC(=O)c3cc(O)c(O)c(O)c3)C(O)C(O)C2OC(=O)c2cc(O)c(O)c(O)c2)c1O	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](N)C(=O)O)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCCCC
The molecule is a stabilizing mitochondrial structure and a stabilizing cytochrome oxidase that impacts tangier disease, diabetic heart disease, and non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation, cholesterol translocation, apoptosis that impacts barth syndrome and aging.	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)O[C@H](COC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCC
The molecule is a cholesterol translocation that impacts diabetic heart disease, aging, barth syndrome, and tangier disease. The molecule is a stabilizing mitochondrial structure, apoptosis, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease.	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a anti bacterial member of the anti biotic class.	Cc1ccc2oc(CN)cc2c1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
It impacts pancreatitis, cardiovascular disease, and atherosclerosis. The molecule is a fat storage and nutrient, belonging to the thyroxine treatment class of molecules, and impacts metabolic syndrome.	CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COC(=O)CCCCCCCCC/C=CC/C=CC/C=CCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCC
The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, apoptosis that impacts barth syndrome and aging. The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts diabetic heart disease, non-alcoholic fatty liver disease, and tangier disease.	CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC(C)CC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC(C)C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCC)OC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCC
The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease and tangier disease. The molecule is a apoptosis and a cholesterol translocation that impacts diabetic heart disease, aging, and barth syndrome.	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCCCCCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC
The molecule is a membrane stabilizer, energy source, thyroxine treatment that impacts cardiovascular disease, pancreatitis, and cancer. The molecule is a nutrient and inflammatory, and it impacts obesity. The molecule is a energy storage and a fat storage, impacting both metabolic syndrome and atherosclerosis.	CCCCCCCCCCCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC)COC(=O)CCCCCCCCCCCCCCC(C)C	CCCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCC(C)C
It impacts cancer treatment.	CCc1c(-c2ccc(O)cc2)cnc(N)c1-c1ccc2c(cnn2C(=O)OC(C)(C)C)c1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc4)cc3)cc2)cc1
The molecule is a anti retroviral, hiv inhibitor, hiv integrase inhibitor, hiv replication inhibitor.	Cc1cc2c(I)c(C(OC(C)(C)C)C(=O)O)c(C)nc2s1	Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5ccccc5)cc5)cc4)cc3)cc2)cc1
The molecule is a cholesterol translocation that impacts barth syndrome, aging, diabetic heart disease, and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, apoptosis that impacts tangier disease.	CCCCCC/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCCCC
The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts non-alcoholic fatty liver disease, diabetic heart disease, and barth syndrome. The molecule is a stabilizing cytochrome oxidase, apoptosis, proton trap for oxidative phosphorylation that impacts tangier disease and aging.	CCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCC(C)C	CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CC/C=CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCC/C=CC/C=CC/C=CC/C=CC/C=CCCC)OC(=O)CCCCC/C=CC/C=CC/C=CC/C=CC/C=CCC)OC(=O)CCCCCCCCCCCCCCCCC
